期刊
EXPERT OPINION ON DRUG SAFETY
卷 21, 期 12, 页码 1441-1443出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14740338.2022.2160445
关键词
romosozumab; osteoporosis; cardiovascular disease